FONAR Corporation ( FONR) Stock. Should you Buy or Sell? $ 14.76
0.91 (5.81 %)
FONAR Corporation Analysis
Updated on 10-09-2022| Symbol | FONR |
| Price | $14.76 |
| Beta | 0.763 |
| Volume Avg. | $10.2 thousand |
| Market Cap | $98.63 M |
| 52 Week Range | $13.56 - $19.32 |
FONAR Corporation opened the day at $14.76 which is +'5.81 % on yesterday's close. FONAR Corporation has a 52 week high of $19.32 and 52 week low of $13.56, which is a difference of $5.76. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $98.63 M and total net profit is $89929765 which means the company is trading at 1.10 times profit to market capitalization. Theoretically, if you were to buy FONAR Corporation for $98.63 M, it would take 15 years to get your money back. FONAR Corporation are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
FONAR Corporation Stock Forecast - Is FONAR Corporation a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Neutral | |
| ROA Score | Neutral | |
| DE Score | Neutral | |
| PE Score | Strong Buy | |
| PB Score | Buy | |
| Overall Recommendation | Buy |
Growth and Value
| PE Ratio | 9.906 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | 0.112 |
Valuing FONAR Corporation
| Price Book Value Ratio | 0.653 | Price To Book Ratio | 0.653 |
| Price To Sales Ratio | 1.325 | Price Earnings Ratio | 11.806 |
How liquid is FONAR Corporation
| Current Ratio | 8.071 |
| Quick Ratio | 7.827 |
Debt
| Debt Ratio | 0.263 | Debt Equity Ratio | 0.347 |
| Long Term Debt To Capitalization | 0.190 | Total Debt To Capitalization | 0.207 |
Latest news about FONAR Corporation
FONAR stock is trading well below book value and remains profitable which is key. Cash, liquidity and equity all continue to grow on the balance sheet.
I think the financial performance has been excellent over the past three quarters. I particularly like the renewed strength of the capital structure. At the same time, the shares are cheap by some measures, and not cheap by others. For that reason, I'm "nibbling" by buying 300 more shares.
Revenue almost hits $90 million & EBIT grows by 25% to surpass $17 million in Fonar's latest fiscal year.
Melville, New York--(Newsfile Corp. - March 31, 2021) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announced today that it has acquired a Stand-Up® MRI facility in Yonkers, New York, from where its diagnostic imaging management subsidiary, Health Management Company of America (HMCA) will provide non-medical management services for Comprehensive MRI of New York, P.C.Tim Damadian, president and CEO of FONAR Corporation, said, "We're very excited about this Yonkers location. Physicians have been...
Blue Tower Asset Management's recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 10.4% for the quarter, outperforming the S&P 500 Index which returned 8.9% in the same quarter. You should check out Blue Tower Asset Management's top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
About FONAR Corporation
Description :
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
